Rare diseases
Investigational molecules
Locations
Piazza La Lizza 7, 53100 Siena, Italy
Philogen S.p.A. focuses heavily on intratumoral and neoadjuvant treatment strategies for basal cell carcinoma, cutaneous squamous cell carcinoma, Merkel cell carcinoma, and melanoma, including disease resistant to anti-PD1 immunotherapy and lesions amenable to local injection.
Its clinical work also includes locally advanced, recurrent, and unresectable skin tumors, with interest in both surgical and non-surgical management settings.
Philogen S.p.A. runs clinical trials in conditions such as Basal cell carcinoma, Skin cancer, Squamous cell carcinoma of skin, Glioma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Germany
AustriaGermanyGermanyGermanyGermanyGermany
FranceGermanyFranceFranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
